RajivRadhakrishnanMD

Psychiatry • New Haven, CT

Associate Professor of Psychiatry at Yale School of Medicine

Join to view full profile

Dr. Radhakrishnan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Radhakrishnan's full profile

Already have an account?

Office
300 George St
Suite 901
New Haven, CT 06511

Summary

Dr. Rajiv Radhakrishnan is a psychiatrist based in New Haven, CT, who completed his residency in psychiatry at Yale-New Haven Medical Center in 2016 after graduating from Yale School of Medicine. His research includes multiple publications focused on psychiatric topics, notably involving schizophrenia, autism, bipolar depression, and substance use. Among his recent works, he explores cognitive functions in women with schizophrenia, synaptic density in autism, and treatment efficacy in bipolar depression. Dr. Radhakrishnan is also involved in several clinical trials, acting as a principal investigator in studies on synaptic density and treatment of schizophrenia, further underlining his active engagement in advancing psychiatric research.

Education & Training

Yale-New Haven Medical CenterResidency, Psychiatry, 2012 - 2016
Yale School of MedicineClass of 2016

Certifications & Licensure

CT State Medical License 2014 - 2025
American Board of Psychiatry and Neurology Psychiatry
American Board of Preventive Medicine Addiction Medicine

Clinical Trials

D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia Start of enrollment: 2002 Sep 01
Completed
Phase 3
SV2A in Older Adults Start of enrollment: 2022 Jul 06
RECRUITING
PHASE1, PHASE2
Roles: Contact, Principal Investigator
SV2 PET Imaging with [11C]APP311 Start of enrollment: 2017 Dec 01
RECRUITING
Roles: Contact
M1 Schizophrenia PET Study Start of enrollment: 2021 Apr 20
COMPLETED
PHASE1
Roles: Principal Investigator, Contact
CBD-Microglia PET Study Start of enrollment: 2021 May 07
RECRUITING
EARLY_PHASE1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

C-UCB-J PET imaging is consistent with lower synaptic density in autistic adults.
David Matuskey, Yanghong Yang, Mika Naganawa, Sheida Koohsari, Takuya Toyonaga
Molecular Psychiatry. 2025-04-01
Cognitive functioning and functional ability in women with schizophrenia and homelessness.
Jayakumar Menon, Suvarna Jyothi Kantipudi, Aruna Mani, Rajiv Radhakrishnan
Schizophrenia Research. Cognition. 2025-03-01
International perspectives on physician knowledge, attitudes, and practices related to medical cannabis.
Shariful A Syed, Jatinder Singh, Hussien Elkholy, Irena Rojnić Palavra, Marko Tomicevic
Frontiers in Public Health. 2025-01-01

Journal Articles

A systematic review of approaches to improve medication adherence in homeless populations with psychiatric disorders
Rachel Hird, Rajiv Radhakrishnan, Jack Tsai, Frontiers in Psychiatry, 12/19/2023

Books/Book Chapters

Marijuana and Madness
Chapter: Cannabis and Psychosis Proneness
Radhakrishnan R, Kamal S, Guloksuz S, van Os JCambridge University PressEdition 3rd,2023

Press Mentions

This Is Your Brain on Legal Drugs: Let’s End the Drug War with a Minimum of Casualties by Following the ScienceJuly 29th, 2014
Cannabis Use and Psychotic DisordersMarch 19th, 2020

Grant Support

Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?YALE UNIVERSITY2021–2026
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?YALE UNIVERSITY2021–2026
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?YALE UNIVERSITY2021–2026
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?YALE UNIVERSITY2021–2026
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?YALE UNIVERSITY2021–2026
Impact of cannabis legalization on prescription drug use and health outcomes in ConnecticutYALE UNIVERSITY2023–2025
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)YALE UNIVERSITY2019–2024
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)YALE UNIVERSITY2019–2024
Effect of Cannabidiol on Microglial Activation and Central Pain-SensitizationYALE UNIVERSITY2019–2024
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)YALE UNIVERSITY2019–2024
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)YALE UNIVERSITY2019–2024
Effect of Cannabidiol on Microglial Activation and Central Pain-SensitizationYALE UNIVERSITY2019–2024
Effect of Cannabidiol on Microglial Activation and Central Pain-SensitizationYALE UNIVERSITY2019–2024